1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: D-0140, NCT00169104
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571BDE28, NCT00372476
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: INJE05-06, NCT00265694
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRUK-SOCCAR, ISRCTN13746987, EU-20602, EUDRACT-2004-001920-19, NCT00309972
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 75 to 90
Sponsor: Other
Protocol IDs: IFCT-0501, NCT00298415
|
|
6.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SLCSG0501, NCT00300729
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1505, E1505, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 21
Sponsor: Other
Protocol IDs: CCLG-EPSSG-RMS-2005, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: HERNATA, NCT00430001
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 19 to 75
Sponsor: Other
Protocol IDs: CT/02.11, NCT00431106
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-15005, 105372, IST 12223, NCT00499109
|
|
12.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2-2-6 STUDY, ZonMw ID 80-82310-98-08006, EudraCT number 2007-005402-53, NCT00536081
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006 BAI02A02[1]-01, NCT00576914
|
|
14.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0553C, NCT00659269
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: PM 0259 CA 304 J1, NCT00683514
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11514, H3E-MC-JMIG, NCT00686959
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11066741577, Eudra-CT-nr 2006-002927-18, NCT00737867
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: Over 20
Sponsor: Other
Protocol IDs: 200803006M, NCT00776724
|
|
19.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-30506, CALGB-30506, NCT00863512
|
|
20.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3144A1-2204, NCT00706030
|
|
21.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: McG 0713, NCT00764972
|
|
22.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CHNMC-08103, 08103, BAYER-CHNMC-08103, NCT00828074
|
|
23.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 200037-014, EudraCT Number: 2008-004148-35, NCT00842712
|
|
24.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ACRIN-6668, RTOG-0235, NCT00083083
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DO03-21-005, NCT00159094
|
